Athersys, Inc. (ATHX) Social Stream



Athersys, Inc. (ATHX): $1.85

0.22 (+13.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ATHX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 384

in industry

Featured Post From StockTwits About ATHX

$ATHX Putting Healios accomplishments aside, what accomplishments did we learn about that ATHX made last quarter related to their core responsibilities. Did we get a good indication where the 3 US clinical trials are at and progress made? Did we get an understanding of the companies mfg approach to scale up. What role is Stow playing and are they planning on moving the headquarters there? I walked away thinking the 3 clinical programs are just getting farther and farther behind. Maybe not but I as a partial owner of the company didn't learn anything new. Also, did we learn about their approach to raising capital to fund the company? Are they planning on using Aspire as the primary vehicle for the foreseeable future or what is their strategy on this? Shareholders need more transparency to be able to judge the risks they are taking. The company needs to rethink its IR strategy and put in place the people and/or outside firm that can help change the markets perception.
GlobalInsights, published August 13, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3544 seconds.